These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 24811899)

  • 1. In vivo delivery of bovine viral diahorrea virus, E2 protein using hollow mesoporous silica nanoparticles.
    Mahony D; Cavallaro AS; Mody KT; Xiong L; Mahony TJ; Qiao SZ; Mitter N
    Nanoscale; 2014 Jun; 6(12):6617-26. PubMed ID: 24811899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunisation of Sheep with Bovine Viral Diarrhoea Virus, E2 Protein Using a Freeze-Dried Hollow Silica Mesoporous Nanoparticle Formulation.
    Mahony D; Mody KT; Cavallaro AS; Hu Q; Mahony TJ; Qiao S; Mitter N
    PLoS One; 2015; 10(11):e0141870. PubMed ID: 26535891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silica vesicles as nanocarriers and adjuvants for generating both antibody and T-cell mediated immune resposes to Bovine Viral Diarrhoea Virus E2 protein.
    Mody KT; Mahony D; Zhang J; Cavallaro AS; Zhang B; Popat A; Mahony TJ; Yu C; Mitter N
    Biomaterials; 2014 Dec; 35(37):9972-9983. PubMed ID: 25239045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mesoporous silica nanoparticles act as a self-adjuvant for ovalbumin model antigen in mice.
    Mahony D; Cavallaro AS; Stahr F; Mahony TJ; Qiao SZ; Mitter N
    Small; 2013 Sep; 9(18):3138-46. PubMed ID: 23625779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bovine viral diarrhea virus E2 protein formulated with a novel adjuvant induces strong, balanced immune responses and provides protection from viral challenge in cattle.
    Snider M; Garg R; Brownlie R; van den Hurk JV; van Drunen Littel-van den Hurk S
    Vaccine; 2014 Nov; 32(50):6758-64. PubMed ID: 25454860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence-optimised E2 constructs from BVDV-1b and BVDV-2 for DNA immunisation in cattle.
    Couvreur B; Letellier C; Olivier F; Dehan P; Elouahabi A; Vandenbranden M; Ruysschaert JM; Hamers C; Pastoret PP; Kerkhofs P
    Vet Res; 2007; 38(6):819-34. PubMed ID: 17727807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility of plasmids encoding bovine viral diarrhea virus type 1 and type 2 E2 in a single DNA vaccine formulation.
    Liang R; Babiuk LA; van Drunen Littel-van den Hurk S
    Vaccine; 2007 Aug; 25(32):5994-6006. PubMed ID: 17597267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a BVDV subunit vaccine produced in alfalfa transgenic plants.
    Peréz Aguirreburualde MS; Gómez MC; Ostachuk A; Wolman F; Albanesi G; Pecora A; Odeon A; Ardila F; Escribano JM; Dus Santos MJ; Wigdorovitz A
    Vet Immunol Immunopathol; 2013 Feb; 151(3-4):315-24. PubMed ID: 23291101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of efficacy of mammalian and baculovirus expressed E2 subunit vaccine candidates to bovine viral diarrhoea virus.
    Thomas C; Young NJ; Heaney J; Collins ME; Brownlie J
    Vaccine; 2009 Apr; 27(17):2387-93. PubMed ID: 19428855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endotoxin-free purification for the isolation of bovine viral diarrhoea virus E2 protein from insoluble inclusion body aggregates.
    Cavallaro AS; Mahony D; Commins M; Mahony TJ; Mitter N
    Microb Cell Fact; 2011 Jul; 10():57. PubMed ID: 21787435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Yeast-surface expressed BVDV E2 protein induces a Th1/Th2 response in naïve T cells.
    Patterson R; Nerren J; Kogut M; Court P; Villarreal-Ramos B; Seyfert HM; Dalby P; Werling D
    Dev Comp Immunol; 2012 May; 37(1):107-14. PubMed ID: 22067741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced mucosal and systemic immune responses obtained by porous silica nanoparticles used as an oral vaccine adjuvant: effect of silica architecture on immunological properties.
    Wang T; Jiang H; Zhao Q; Wang S; Zou M; Cheng G
    Int J Pharm; 2012 Oct; 436(1-2):351-8. PubMed ID: 22721849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracellular protein delivery by hollow mesoporous silica capsules with a large surface hole.
    Lim JS; Lee K; Choi JN; Hwang YK; Yun MY; Kim HJ; Won YS; Kim SJ; Kwon H; Huh S
    Nanotechnology; 2012 Mar; 23(8):085101. PubMed ID: 22293239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversible pore-structure evolution in hollow silica nanocapsules: large pores for siRNA delivery and nanoparticle collecting.
    Chen Y; Chu C; Zhou Y; Ru Y; Chen H; Chen F; He Q; Zhang Y; Zhang L; Shi J
    Small; 2011 Oct; 7(20):2935-44. PubMed ID: 21901827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunocompetent truncated E2 glycoprotein of bovine viral diarrhea virus (BVDV) expressed in Nicotiana tabacum plants: a candidate antigen for new generation of veterinary vaccines.
    Nelson G; Marconi P; Periolo O; La Torre J; Alvarez MA
    Vaccine; 2012 Jun; 30(30):4499-504. PubMed ID: 22554468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Facile synthesis of monodispersed mesoporous silica nanoparticles with ultralarge pores and their application in gene delivery.
    Kim MH; Na HK; Kim YK; Ryoo SR; Cho HS; Lee KE; Jeon H; Ryoo R; Min DH
    ACS Nano; 2011 May; 5(5):3568-76. PubMed ID: 21452883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The shape and size effects of polycation functionalized silica nanoparticles on gene transfection.
    Lin X; Zhao N; Yan P; Hu H; Xu FJ
    Acta Biomater; 2015 Jan; 11():381-92. PubMed ID: 25219349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hsp110-mediated enhancement of CD4+ T cell responses to the envelope glycoprotein of members of the family Flaviviridae in vitro does not occur in vivo.
    McLaughlin K; Carr VB; Iqbal M; Seago J; Lefevre EA; Robinson L; Prentice H; Charleston B
    Clin Vaccine Immunol; 2011 Feb; 18(2):311-7. PubMed ID: 21147937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-specific intracellular anticancer drug delivery from mesoporous silica nanoparticles with pH sensitivity.
    Luo Z; Cai K; Hu Y; Zhang B; Xu D
    Adv Healthc Mater; 2012 May; 1(3):321-5. PubMed ID: 23184747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adsorption and release of biocides with mesoporous silica nanoparticles.
    Popat A; Liu J; Hu Q; Kennedy M; Peters B; Lu GQ; Qiao SZ
    Nanoscale; 2012 Feb; 4(3):970-5. PubMed ID: 22200056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.